Dergiler / International Journal of Plant Based Pharmaceuticals / 2022 / Cilt: 2 - Sayı: 1

Chemical composition and cholinesterase, tyrosinase, alpha-amylase and alpha-glucosidase inhibitory activity of the essential oil of Salvia tomentosa

Sayfa
1–16
Yayın Tarihi
2022-06-15
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Ligand binding assays (LBA) to be performed between the monoterpenes and enzymes in question may constitute the next step in confirming their competitive inhibitory capacity.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The aim of this study was to determine the chemical composition of Salvia tomentosa (Miller) essential oil and to examine its inhibitory effect on acetylcholinesterase (AChE), butyrylcholinesterase (BChE), tyrosinase, α-amylase and α-glucosidase in vitro.
📊
Temel Bulgular & Veri:The presence of 60 compounds representing 98.2% of the essential oil was determined.
💡
Sonuç & Katkı:Ligand binding assays (LBA) to be performed between the monoterpenes and enzymes in question may constitute the next step in confirming their competitive inhibitory capacity.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Salvia tomentosa · essential oil · enzyme inhibitory activity

Abstract

The aim of this study was to determine the chemical composition of Salvia tomentosa (Miller) essential oil and to examine its inhibitory effect on acetylcholinesterase (AChE), butyrylcholinesterase (BChE), tyrosinase, α-amylase and α-glucosidase in vitro. In this study, the interaction between the main components of essential oil and the enzymes in question was analyzed through molecular docking analyses. The presence of 60 compounds representing 98.2% of the essential oil was determined. The major compounds of the oil were camphor (9.35%), γ-muurolene (8.37%), α-pinene (7.59%), α-caryophyllene (6.25%), viridiflorol (5.13), δ-cadinene (5.01%), and terpinene-4-ol (5.01 %). The oil exhibited higher inhibitory activity on BChE than on AChE. The BChE inhibitory activity of the oil was determined to be 16.48 mg GALAEs/g. The oil showed 47.13 mg KAEs/g inhibitory activity on tyrosinase. The inhibitory activities of the essential oil on α-glucosidase and α-amylase were determined as 703.29 and 694.75 mg ACEs/g, respectively. Based on docking binding energies, δ-cadinene, viridiflorol, γ-muurolene and α-caryophyllene were determined to be the most promising ligands showing the highest affinity (min. -6.90 kcal/mol; max. -8.40 kcal/mol) against α-amylase, AChE and BChE. However, all four ligands were found to exhibit low affinity (min. -5.50 kcal/mol; max. -5.90 kcal/mol) against tyrosinase. Considering in silico physicochemical properties, drug-like features (Lipinski's rule of 5) and intracellular targets, δ-cadinene, viridiflorol, γ-muurolene and α-caryophyllene possess hit features and do not show non-specific enzyme or protein affinity. Ligand binding assays (LBA) to be performed between the monoterpenes and enzymes in question may constitute the next step in confirming their competitive inhibitory capacity.

🔖

Bu Makaleye Atıf Yap

KOÇER, M., İSTİFLİ, E. S. (2022). Chemical composition and cholinesterase, tyrosinase, alpha-amylase and alpha-glucosidase inhibitory activity of the essential oil of Salvia tomentosa. International Journal of Plant Based Pharmaceuticals, Cilt: 2 - Sayı: 1, 1–16. https://ajindex.com/articles/852749

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Aghajari, N., Feller, G., Gerday, C., Haser, R., 2002. Structural basis of alpha-amylase activation by chloride. Protein Science, 11, 1435-1441.
  2. Ak, G., Zengin, G., Ceylan, R., Fawzi Mahomoodally, M., Jugreet, S., Mollica, A., Stefanucci, A., 2021. Chemical composition and biological activities of essential oils from Calendula officinalis L. flowers and leaves. Flavour and Fragrance Journal, 36, 554-563.
  3. Askun, T., Baser, K.H.C., Tumen, G., Kurkcuoglu, M., 2010. Characterization of essential oils of some Salvia species and their antimycobacterial activities. Turkish Journal of Biology, 34, 89-95.
  4. Ballante, F., 2018. Protein-Ligand Docking in Drug Design: Performance Assessment and Binding-Pose Selection. Methods in Molecular Biology, 1824, 67-88.
  5. Bardakci, H., Servi, H., Polatoglu, K., 2019. Essential Oil Composition of Salvia candidissima Vahl. occidentalis Hedge, S. tomentosa Miller and S. heldreichiana Boiss. Ex Bentham from Turkey. Journal of Essential Oil Bearing Plants, 22, 1467-1480.
  6. Bonesi, M., Menichini, F., Tundis, R., Loizzo, M.R., Conforti, F., Passalacqua, N.G., Statti, G.A., Menichini, F., 2010. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of Pinus species essential oils and their constituents. Journal of Enzyme Inhibition and Medicinal Chemistry, 25, 622-628.
  7. Bouyahya, A., Lagrouh, F., El Omari, N., Bourais, I., El Jemli, M., Marmouzi, I., Salhi, N., Faouzi, M.E., Belmehdi, O., Dakka, N., Bakri, Y., 2020. Essential oils of Mentha viridis rich phenolic compounds show important antioxidant, antidiabetic, dermatoprotective, antidermatophyte and antibacterial properties. Biocatalysis and Agricultural Biotechnology, 23, 101471. Brayer, G.D., Luo, Y., Withers, S.G., 1995. The structure of human pancreatic α‐amylase at 1.8 Å resolution and comparisons with related enzymes. Protein Science, 4, 1730-1742.
  8. Burlando, B., Clericuzio, M., Cornara, L., 2017. Moraceae plants with tyrosinase inhibitory activity: A review. Mini Reviews in Medicinal Chemistry, 17, 108-121.
  9. Chang, T.S., 2009. An updated review of tyrosinase inhibitors. International Journal of Molecular Sciences, 10, 2440-2475.
  10. Chang, T.S., 2012. Natural melanogenesis inhibitors acting through the down-regulation of tyrosinase activity. Materials, 5, 1661-1685.
  11. Chaudhury, A., Duvoor, C., Reddy Dendi, V.S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N.S., Montales, M.T., Kuriakose, K., 2017. Clinical review of antidiabetic drugs: implications for type 2 dia